Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatin.
D000596:Amino Acids / Q000494:pharmacology; D000818:Animals; D002733:Chlorophenols; D003167:Complement Activation / Q000187:drug effects*; D050577:Complement C3-C5 Convertases / Q000037:antagonists & inhibitors; D003179:Complement C3b / Q000378:metabolism; D003170:Complement Pathway, Alternative / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes; D006461:Hemolysis; D006801:Humans; D010456:Peptides, Cyclic; D011817:Rabbits; D011951:Receptors, Complement; D012756:Sheep; D013302:Streptomyces
D000596:Amino Acids; D002733:Chlorophenols; D010456:Peptides, Cyclic; D011951:Receptors, Complement; C023490:complestatin; D003179:Complement C3b; D050577:Complement C3-C5 Convertases